Depomed to Participate at the Annual Piper Jaffray Healthcare Conference
November 21 2017 - 4:05PM
Depomed, Inc. (NASDAQ:DEPO) today announced that senior management
will participate in a fireside chat at the 29th Annual Piper
Jaffray Healthcare Conference at 8:30 am ET (5:30 am PT) on
Tuesday, November 28, 2017 in New York, New York.
The fireside chat will be webcast live and may be accessed via
the Investor Relations page of the Depomed website at
www.depomed.com. A recording of this event will be archived
for 30 days on the Company's website.
About Depomed
Depomed is a leading specialty pharmaceutical company focused on
enhancing the lives of the patients, families, physicians,
providers and payors we serve through commercializing innovative
products for pain and neurology related disorders. Depomed markets
five medicines with areas of focus that include mild to severe
acute pain, moderate to severe chronic pain, neuropathic pain and
migraine. Depomed is headquartered in Newark, California. To learn
more about Depomed, visit www.depomed.com.
Investor Contact:
Christopher Keenan VP, Investor Relations and Corporate
Communications 510-744-8000 ckeenan@depomed.com
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Sep 2023 to Sep 2024